US-based medical device company Medtronic launched new drug-eluting stent (DES) technology Resolute Onyx for the first time in India. It has been introduced in Hyderabad, Kolkata, Kochi, Mumbai and will be launched in Bangalore and Delhi shortly. The technology is based on Resolute Integrity platform which offers flexibility in the form of sleek.
Two new prefilled drug delivery devices - one for chronic diseases and another for vaccination are introduced at Technovation 2015 by BD Medical - Pharmaceutical Systems.
Medanta- The Medicity, introduced Vacuum Assisted Breast Biopsy Technology for the treatment of breast cancer.
Breast canceris cancer that develops from breast tissue.In India, number of young and middle aged women suffering from disease.
Indian Pharmacopoeia Commission (IPC) recently released the guidance document for monographs development of herbs and herbal products. This manual is aimed to provide guidelines for the stakeholders of IP who intend to submit herbs and herbal products monographs, candidate material for phytochemicals reference substances and botanical reference substances to IPC.
[adsense:336x280:8701650588]
Ideal Cures Pvt Ltd, has received third EXCiPACT certificate for its manufacturing site located at Vasai. The plant at Vasai, the main manufacturing unit of the company, has received EXCiPACT certification for film coating materials (Instacoat, Instanute, Instaspray, and Instamask) and extended cooling boosters (Ecocool). With receipt of this third certificate all manufacturing plants of Ideal Cures located in India at Vasai, Jammu and Khambhat are EXCiPACT certified.
Teijin Pharma Limited, the core company of the Teijin Group’s medical and pharmaceutical business, has launched Mucosolvan L tablet 45 mg (ambroxol hydrochloride), a reduced-size tablet version of the company's novel expectorant drug.
SkylineDx, a Dutch-based innovative biotechnology company specialising in the development and commercialization of genetic tests, has launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods.
[adsense:336x280:8701650588]
Lupin, India's fifth largest drug maker, announced the acquisition of Russia's Biocom, a fast-growing generic pharmaceuticals firm, for an undisclosed amount.
Lupin Chief Executive Officer, Vinita Gupta, said: "We are excited about our entry into the Russian market through Biocom. Russia is an attractive market and this acquisition will also enable our expansion into neighbouring markets as well as other Eastern European markets in the future."
Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company, launch generic Aggrenox (aspirin/extended-release dipyridamole) capsules in the United States which are used to lower the risk of stroke in people who have had a mini-stroke (transient ischemic attack or TIA) or stroke due to a blood clot.
Glenmark Pharmaceuticals, has received approval from the US Food and Drug Administration (US FDA) for its cholesterol-lowering drug Ezetimibe. Ezetimibe is the generic version of Merck-Schering Plough's cholesterol-lowering drug with the product name Zetia.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
